FDA's New Rules Boost American Jobs and Safeguard Domestic Medicine Supply Chain

The FDA's new moves are bolstering American jobs and safeguarding the nation's medicine supply by reducing reliance on foreign manufacturers. Over 70% of key prescription production facilities are now located in the US. This shift aims to address concerns about supply chain vulnerabilities highlighted for decades. As a result, pharmaceutical companies can now prioritize domestic production and more effectively control the quality and delivery of essential medicines.